Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-escalation comparison of rocuronium versus suxamethonium for rapid sequence intubation
2004-002715-92Phase 4Completed
- Sponsor
- Royal Group Hospitals
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of rocuronium (2 arms), sponsored by Royal Group Hospitals. Primary endpoint: Intubation conditions score. Started Jul 2005; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on 2004-002715-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002715-92.